TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Imagion Biosystems Ltd. ( (AU:IBX) ) has shared an update.
Imagion Biosystems has entered a collaboration with Wayne State University to enhance its molecular imaging capabilities using its MagSense® technology. This partnership, alongside Siemens Healthineers, aims to develop advanced MRI protocols and quantitative imaging techniques that enable AI-based cancer diagnostics. The collaboration is expected to improve diagnostic accuracy, democratize access to advanced imaging, and accelerate the development of AI diagnostics, potentially transforming cancer detection and patient care.
More about Imagion Biosystems Ltd.
Imagion Biosystems Ltd. operates in the healthcare industry, focusing on the early detection of cancer through its proprietary MagSense® imaging technology. The company collaborates with leading organizations to enhance molecular imaging capabilities, aiming to improve diagnostic accuracy and patient outcomes.
Average Trading Volume: 4,658,224
Technical Sentiment Signal: Sell
Current Market Cap: A$3.94M
See more insights into IBX stock on TipRanks’ Stock Analysis page.